Kanad Hospital Neonatal-Perinatal Medicine Services & In cooperation with the
College of Medicine and Health Sciences, UAEU, under the patronage of the
Dean of the Faculty of Medicine, The respected Prof. Dr. Juma Al Kabbi.
WELCOME MESSAGE
Greetings!
It is our pleasure to invite you to attend Kanad Hospital 2nd Annual Neonatal - Perinatal Medicine Scientific Meeting that will be held on November 18 - 19, 2022 in Radisson Blu Hotel, Al Ain, Abu Dhabi, UAE.
The programme will cover a broad range of topics such as latest trends within the field of fetal medicine and advances of management within Neonatology: Invasive & Non-Invasive, Neonatal Ventilation, Cardiology, Neonatal Infection, Neonatal Encephalopathy, Neonatal Resuscitation, Neonatal GI, Neonatal Surgery, Neonatal Orthopedics, Genetic & Metabolic Disorders.
The conference will offer a superb opportunity for healthcare professionals to share their best practices, to network within the same group of interest, and to create and strengthen clinical collaborations.
We look forward in welcoming you to this conference!
Dr. Moh’d Yousef Khalil
Conference Chairman
Pediatrics/Neonatology Consultant
Dr. Fares Chedid
Conference Co-Chairman
Pediatrics Neonatology Consultant
Department Head
Dr. Nicholas Hoque
Organizing Committee
Pediatrics/Neonatology Consultant
OBJECTIVES
-
Explore the latest trends within the field of fetal
medicine.
-
Advances of Management within Neonatology:
Invasive & Non-Invasive Neonatal Ventilation
Cardiology,
Neonatal Infection
Neonatal Encephalopathy
Neonatal Resuscitation
Neonatal GI
Neonatal Surgery
Neonatal Orthopedics
Genetic & Metabolic Disorders
TARGET AUDIENCE
-
Neonatologists
-
Pediatricians
-
Family Medicine Clinicians
-
Fetal Medicine Clinicians
-
General Practitioners
-
Midwives
-
Nurses
-
Obstetricians
-
Pharmacists
-
Radiologists
-
Anesthesiologists
-
Educators
-
Researchers
-
Residents/Fellows/Interns
-
Students
Registration
GOLD SPONSOR
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolic Diseases and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
They are focused on creating genuinely innovative medicines and improving access to them. In this way, they deliver the greatest benefit to patients, healthcare systems and societies globally. They have three priorities designed to deliver our growth through innovation strategy - Accelerate Innovative Science; Deliver Growth and Therapy Area Leadership; and Be a Great Place to Work.
At AstraZeneca, sustainability is part of our DNA, embedded in everything they do, from the lab to the patient. Working in partnership with all the stakeholders, they are harnessing the power of science and innovation to deliver life-changing medicines in a way that is respectful of our planet.
SILVER SPONSOR
We are an international group based in Parma, research-oriented, with over 85 years of experience, present in 30 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).